Public health strategies, from vaccination to improving sanitary conditions, may have different impacts depending on whether ...

Oct. 23, 2024 — Lyme borreliosis is the most common tick-borne infectious disease in Europe. Up to 70,000 new cases are estimated each year in Austria alone. The bacterial infection can cause ...

Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada (C.S., K.J.R). Centre for Infection, Immunity ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd.

There are several challenges in measuring disease progression in PD. This includes the fluctuating nature of the disease and the high variability in progression rates in PD patients. Due to the ...

A recently developed blood test for Alzheimer's disease helps in diagnosing the condition and indicating ... As current treatments for Alzheimer's are most effective in the early stages of the ...

escalating his rhetoric as talks have resulted in little progress toward a real cease-fire in Ukraine. On Friday, Putin called for “interim governance” in Ukraine under the auspices of the ...

(Reuters) -Corcept Therapeutics said on Monday its experimental drug in combination with chemotherapy helped delay progression of a type of ovarian cancer in a late-stage trial. The company's ...

A blood test developed to detect Alzheimer’s disease can also show how far the disease has progressed and tell if symptoms are due to Alzheimer’s or another cause, a study finds. The report ...

The team wanted to know if the ratio between YWHAG and NPTX2 could predict the progression of Alzheimer’s disease in people with a diagnosis or those with a genetic risk of the disease. They ...

Current Alzheimer’s therapies are most effective in early stages of the disease. Having a relatively easy and reliable way to gauge how far the disease has progressed could help doctors determine ...